JACCX | VIGAX | JACCX / VIGAX | |
Total Expense Ratio | 1.59 | 0.05 | 3,180% |
Annual Report Gross Expense Ratio | 1.59 | 0.05 | 3,180% |
Fund Existence | 23 years | 25 years | - |
Gain YTD | 13.616 | 12.589 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.9B | 324B | 7% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 4.68 | 24.02 | 19% |
Returns for 3 years | 32.03 | 73.68 | 43% |
Returns for 5 years | 13.15 | 107.21 | 12% |
Returns for 10 years | 34.50 | 321.60 | 11% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BME | 36.36 | 0.57 | +1.60% |
Blackrock Health Sciences Trust | |||
BBEU | 68.72 | 0.22 | +0.32% |
JPMorgan BetaBuilders Europe ETF | |||
JHCP | 25.22 | 0.01 | +0.04% |
JHancock Core Plus Bond ETF | |||
XNOV | 36.15 | -0.02 | -0.06% |
FT Vest US Eq Enh & Mod Buf ETF-Nov | |||
BNOV | 42.48 | -0.07 | -0.17% |
Innovator US Equity Buffer ETF Nov |